← Back to patent-cliff list
CAS 112885-34-4
4-Acetamido-5-chloro-2-ethoxy-N-([4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl)benzamide
Codes: Mosapride Citrate-063
Application context (from source-drug indications)
GastritisMosapride CitrateEnteral feeding intoleranceMosapride CitrateIrritable bowel syndromeMosapride CitrateDyspepsiaMosapride CitrateConstipationMosapride Citrate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Mosapride Citrate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Morpholin-2-ylmethanamine→4-Amino-5-chloro-2-ethoxybenzoic acid→4-Amino-5-chloro-2-ethoxy-N-(morpholin-2-ylmethyl)benzamide→4-Acetamido-5-chloro-2-ethoxy-N-[(morpholin-2-yl)methyl]benzamide→1-(Chloromethyl)-4-fluorobenzene→4-Acetamido-5-chloro-2-ethoxy-N-([4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl)benzamide
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.